Attenuation of cardioprotective effect by postconditioning in coronary stenosed rat heart and its restoration by carvedilol

Circulation Journal

Volumn 72, Issue 12, 2008, Pages 2081-2086

  Oikawa, Masayoshi ^a   Yaoita, Hiroyuki ^a   Watanabe, Kenichi ^a   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Beta blocker; Ischemia; Postconditioning

Indexed keywords

CARVEDILOL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; MALE; NONHUMAN; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARBAZOLES; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHORYLATION; PROPANOLAMINES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 56849116269     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0098     Document Type: Article

References (16)

1. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Vinten-Johansen J, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-H588.
2. Tang XL, Sato H, Tiwari S, Dawn B, Bi Q, Bolli R, et al. Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 minutes. Am J Physiol Heart Circ Physiol 2006; 291: H2308-H2317.
3. Zatta AJ, Kin H, Lee G, Wang N, Zhao ZQ, Vinten-Johansen J, et al. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res 2006; 70: 315-324.
4. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: A form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 2004; 95: 230-232.
5. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671.
6. Watanabe K, Yaoita H, Ogawa K, Oikawa M, Maehara K, Maruyama Y. Attenuated cardioprotection by ischemic preconditioning in coronary stenosed heart and its restoration by carvedilol. Cardiovasc Res 2006; 71: 537-547.
7. Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 2006; 70: 240-253.
8. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial. Lancet 2001; 357: 1385-1390.
9. Yaoita H, Yoshinari K, Maehara K, Sando M, Watanabe K, Maruyama Y. Different effects of a high-cholesterol diet on ischemic cardiac dysfunction and remodeling induced by coronary stenosis and coronary occlusion. J Am Coll Cardiol 2005; 45: 2078-2087.
10. Yoshinari K, Yaoita H, Maehara K, Maruyama Y. Different therapeutic responses to treadmill exercise of heart failure due to ischemia and infarction in rats. Cardiovasc Res 2005; 65: 457-468.
11. Darling CE, Jiang R, Maynard M, Whittaker P, Vinten-Johansen J, Przyklenk K. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: Role of ERK1/2. Am J Physiol Heart Circ Physiol 2005; 289: H1618-H1626.
12. Yaoita H, Sakabe A, Maehara K, Maruyama Y. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Circulation 2002; 105: 975-980.
13. Schwartz LM, Lagranha CJ. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: Role of ERK1/2. Am J Physiol Heart Circ Physiol 2005; 289: H1618-H1626.
14. Huang SS, Wei FC, Hung LM. Ischemic preconditioning attenuates postischemic leukocye-endothelial cell interactions: Role of nitric oxide and protein kinase C. Circ J 2006; 70: 1070-1075.
15. Bao N, Minatoguchi S, Kobayashi H, Yasuda S, Kawamura I, Iwasa M, et al. Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits. Circ J 2007; 71: 1622-1628.
16. Hasegawa H, Takano H, Shiraishi H, Ueda K, Niitsuma Y, Tadokoro H, et al. Intracoronary injection of granulocyte colony-stimulating factor ameliorates the progression of left ventricular remodeling after myocardial ischemia/reperfusion in rabbits. Circ J 2006; 70: 942-944.